The global cell & gene therapy market is one of the fastest-growing segments of the global regenerative medicine market. The market is growing at a healthy rate and this trend is expected to continue during the forecast period. This surge can be attributable to the growing prevalence of various chronic diseases like cancer, cartilage related problems, wounds, diabetic foot ulcer, genetic diseases, and other rare diseases across the globe. For instance, the prevalence of cancer and diabetes is increasing among the global population, and the medical solutions through conventional treatment methods are limited. There is a large unmet need in the treatments available today, and this need is fulfilled by cell & gene therapies. The market is witnessing steady growth due to the increased availability of funding from various public and private institutes. In addition, there is increased support from the regulatory bodies for product approvals and providing fast-track designations to the products, which encourages vendors to manufacture the products at a faster rate. In addition, the government in various major nations is creating awareness about the cell & gene therapy among the population and bringing various strategies to facilitate affordability and payments for these treatments.

1 RESEARCH METHODOLOGY 

2 RESEARCH OBJECTIVES 

3 RESEARCH PROCESS

4 SCOPE & COVERAGE 

4.1 MARKET DEFINITION 

5 REPORT ASSUMPTIONS & CAVEATS 

6 MARKET AT A GLANCE 

7 INTRODUCTION 

8 MARKET OPPORTUNITIES & TRENDS 

9 MARKET GROWTH ENABLERS 

10 MARKET RESTRAINTS 

11 MARKET LANDSCAPE